Clinical Research Facility
Forest Hills, New York
We've found
1 trials
at this facility
Atopic Dermatitis Clinical Trial
Updated: 2/7/2017
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 2/7/2017
Click here to add this to my saved trials